DMK

DMK Pharmaceuticals Corporation Common Stock
DMK

Overview Fund Activity
Delisted

DMK was delisted on the 6th of February, 2024.

Back to rankings

29 hedge funds and large institutions have $15.7M invested in DMK Pharmaceuticals Corporation Common Stock in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 2 closing their positions.

Holders
29
Holders Change
+4
Holders Change %
+16%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
6
Increased
5
Reduced
9
Closed
2
Calls
$83K
Puts
$2K
Net Calls
+$81K
Net Calls Change
+$6K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$177K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.69M
3
SBL
3
Sargent Bickham Lagudis
Colorado
$29K
4
Walleye Trading
4
Walleye Trading
New York
$773K
5
CG
5
Cutler Group
California
$11K

Top Sellers

1
Marshall Wace
1
Marshall Wace
United Kingdom
$2.39M
2
SCM
2
Sio Capital Management
New York
$7.74M
3
Northern Trust
3
Northern Trust
Illinois
$249K
4
RJA
4
Raymond James & Associates
Florida
$252K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$100K
Name Market Value Shares Shares
Change 		Shares
Change %
Citigroup
26
Citigroup
New York
$1K 215 -785 -79%
Bank of America
27
Bank of America
North Carolina
$1K 236 -117 -33%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$254 41,564 – –
PAIM
29
Punch & Associates Investment Management
Minnesota
– – -400 Closed
Group One Trading
30
Group One Trading
Illinois
– – -216 Closed
CPA
31
Cowen Prime Advisors
New York
$0 6 +6 New
1
2